|Articles|April 4, 2016 (Updated: November 15, 2020)

May 2016 — Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding

Author(s)DIA

Pharmaceutical compounding is an essential aspect of medicine in the US, although with inherent risks that must be understood and managed. In May 2016, the Special Section of TIRS overviews the history of compounding, identifies the special challenges associated with the practice, and offers improvements for patient safety.

Read more here.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content